metastatic malignant neoplasm in the bone
Showing 1 - 25 of 27
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Radium-223
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 20, 2023
Clear Cell Renal Cell Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Lymph Nodes Trial in
Recruiting
- Clear Cell Renal Cell Carcinoma
- +6 more
- Cabozantinib
- +4 more
-
Anchorage, Alaska
- +828 more
Feb 2, 2023
Metastatic Ewing Sarcoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Bone Marrow Trial in Canada,
Active, not recruiting
- Metastatic Ewing Sarcoma
- +5 more
- Cyclophosphamide
- +11 more
-
Birmingham, Alabama
- +316 more
Jan 28, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +5 more
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +26 more
Jan 25, 2023
Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,
Recruiting
- Advanced Renal Cell Carcinoma
- +8 more
- Cabozantinib S-malate
- +3 more
-
Birmingham, Alabama
- +35 more
Jan 24, 2023
Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in
Active, not recruiting
- Metastatic Malignant Neoplasm in the Bone
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 4, 2023
Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder
Active, not recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +35 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +7 more
Jan 3, 2023
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial
Active, not recruiting
- Hormone-Resistant Prostate Cancer
- +6 more
- Pembrolizumab
- pTVG-HP Plasmid DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 8, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Adenocarcinoma Trial in
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +5 more
- Questionnaire Administration
- Tin Sn 117m Pentetate
-
Lexington, KentuckyUniversity of Kentucky/Markey Cancer Center
Nov 26, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston
Completed
- Castration-Resistant Prostate Carcinoma
- +5 more
- Durvalumab
- Tremelimumab
-
Houston, TexasM D Anderson Cancer Center
Nov 9, 2022
Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los
Terminated
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022
Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen
Recruiting
- Castration-Resistant Prostate Carcinoma
- +7 more
- Biopsy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,
Active, not recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +6 more
- Anastrozole
- +6 more
-
Atlanta, Georgia
- +9 more
Oct 12, 2022
Bone Metastases, Cancer Survivor, Metastatic Malignant Tumor in the Bone Trial in Houston (Monitoring Device, Physical Activity
Terminated
- Bone Metastases
- +2 more
- Monitoring Device
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2022
Malignant Tumor, Metastatic Malignant Tumor in the Bone, Pain Trial in Winston-Salem (External Beam Radiation Therapy,
Recruiting
- Malignant Neoplasm
- +2 more
- External Beam Radiation Therapy
- +3 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Oct 6, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
-
San Francisco, California
- +1 more
Sep 20, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle
Active, not recruiting
- Castration-Sensitive Prostate Carcinoma
- +7 more
- Antiandrogen Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Metastatic Malignant Tumor, Metastatic Malignant Tumor in the Bone Trial in Houston (Fludeoxyglucose F-18, Magnetic Resonance
Active, not recruiting
- Metastatic Malignant Neoplasm
- Metastatic Malignant Neoplasm in the Bone
- Fludeoxyglucose F-18
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Solid Tumor Trial
Withdrawn
- Locally Advanced Malignant Solid Neoplasm
- +3 more
- (no location specified)
May 24, 2022
Bone Pain, Metastatic Malignant Tumor in the Bone, Plasma Cell Myeloma Trial in United States (Quality-of-Life Assessment,
Recruiting
- Bone Pain
- +2 more
- Quality-of-Life Assessment
- +2 more
-
Duarte, California
- +7 more
Feb 25, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Bone Trial in
Recruiting
- Castration-Resistant Prostate Carcinoma
- +17 more
- Cryosurgery
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 29, 2021
Blood and Tissue Samples From Locally Recurrent or Metastatic
Recruiting
- Localized Renal Pelvis and Ureter Urothelial Carcinoma
- +10 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 21, 2021
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Seattle
Terminated
- Castration-Resistant Prostate Carcinoma
- +3 more
- Carboplatin
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 3, 2021
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Bone Trial in Worldwide
Suspended
- Anatomic Stage IV Breast Cancer AJCC v8
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +163 more
Sep 22, 2021
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Recurrent Prostate Carcinoma Trial in Buffalo,
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Laboratory Biomarker Analysis
- Radiation Therapy
-
Buffalo, New York
- +1 more
Aug 4, 2021